Answers are grounded in this paper and cite their sources.
OBJECTIVE: To analyse the achievement and long-term clinical impact of different types of renal response (RR) in 147 patients with lupus nephritis (LN). METHODS: Four mutually exclusive levels of proteinuria at 12 months were defined: DR (deep remission, Pr/Cr ≤0.15 g/g), CRR 0.15-0.5 (complete renal response with Pr/Cr >0.15-0.5 g/g), RR 0.5-0.7 (renal response with Pr/Cr >0.5-0.7 g/g) and NR (no response, Pr/Cr >0.7 g/g). Early CRR (Pr/Cr ≤0.5 g/g at 6 months) was also studied. The occurrence of long-term renal outcomes (CKD and ESKD), renal or glucocorticoid (GC)-related damage and relapses was analysed. Multivariate Cox analysis were adjusted by clinical clusters of LN and antiproteinuric drugs use. RESULTS: 23% achieved DR, 34% CRR 0.15-0.5, 7.5% RR 0.5-0.7 and 35% NR. Evolution to CKD increased with growing levels of proteinuria (p = 0.002). No patients with DR or CRR 0.15-0.5 progressed towards ESKD. In the Cox models, patients in the DR and CRR 0.15-0.5, but not those in the RR 0.5-0.7 group, were less likely to evolve to CKD and to accrue damage compared to NR. Patients with early CRR were more likely to achieve DR and less likely to develop CKD (8% vs 31.5%, p = 0.001). No effects of proteinuria levels on relapses were seen. CONCLUSION: CRR with Pr/Cr ≤0.5 at 12 months is a feasible good prognostic target, whilst the extension towards Pr/Cr ≤0.7 includes patients with more adverse prognosis. DR is a more difficult but ideal objective. The achievement of early CRR at 6 months should be considered a desirable intermediate goal.
No takes yet. Share an insight, caveat, or question.
Ruiz‐Irastorza et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: